Japanese Pharmaceutical Company Touts Ivermectin’s ‘Antiviral Effect’ Against COVID-19

  • by:
  • 09/21/2022

Japanese trading and pharmaceutical company Kowa Co. Ltd. said Monday that ivermectin shows an “antiviral effect” against the omicron variant and others. 

The statement was based on joint, non-clinical trials the company has been running with Tokyo’s Kitasato University, Just the News reports

It is no secret that the drug is extremely controversial. It is not approved for use in treating the virus in Japan, and in the U.S., the FDA continues to caution against its use. 

While the FDA argues there have been a number of cases in which people were hospitalized after self-medicating with the drug, there have also been several cases of it being used to successfully treat COVID-19 in unvaccinated and vaccinated patients. 

Ivermectin is currently being studied in the United Kingdom in a trial through Oxford University. 

N/A by N/A is licensed under N/A

Opinion

View All

WATCH: Eric Metaxas Explains Why 'Intellectually Honest' People Recognize Atheism As 'Preposterous'

'I don't have any doubt that if you are intellectually honest, you have to conclude—you must conclude...

WaPo, NYT Give Glowing Reviews to New Play Sympathetic to Pedophiles

This is the pipeline to mainstreaming pedophilia acceptance in contemporary American culture....

MCCOTTER: An Ode to the Adage 'Mind Your Own Business'

Minding everyone else’s business is being promoted as a social good....

POSOBIEC: Elon Musk Is Exposing SBF-Funded Media, Just Like Trump Went After Fake News

Posobiec suggested that Musk was beginning to do to the media what Trump had been doing for years, bu...

© 2022 Human Events, Privacy Policy